Home PC News Intralink-Spine, Inc. Adds Clinical Sites in Australia

Intralink-Spine, Inc. Adds Clinical Sites in Australia

Take the most recent VB Survey to share how your organization is implementing AI right now.


LEXINGTON, Ky.–(BUSINESS WIRE)–July 14, 2020–

Intralink-Spine, Inc. (ILS) broadcasts the enlargement of medical trials for his or her patented injectable medical gadget, Réjuve ®, supposed in Australia for the remedy of low again ache. “We’re pleased that Dr. Yu and Dr. Green have joined Dr. Rosenberg to participate in the GEM-SE clinical study for low back pain,” says Lyle Hawkins, CEO of Intralink-Spine, Inc.

“Low back pain due to degenerative disc disease is very common among my patients yet there are limited non-surgical options out there. I was very keen to be part of this intra-discal treatment study because if proven effective, Réjuve could be an alternative minimally-invasive therapy for this subset of patients. Furthermore, being an investigator allows me to contribute to the development of this particular type of therapy,” says Dr. James Yu of Sydney Spine & Pain.

According to Hawkins, “We believe the Réjuve medical device, which structurally reinforces the native intervertebral disc itself, is going to be a better treatment option for many Australian patients with low back pain. Réjuve has shown to have rapid results like an epidural steroid injection, but with potential long-term positive effects similar to a successful fusion.”

“At present there is not a targeted anatomically-specific treatment for symptomatic lumbar disc disease. The team at PainMedSA are excited to explore the prospects of a restorative and anatomically specific treatment for this disabling condition, with Réjuve,” states Dr. Matthew Green.

“This unique nano-tethering polymeric biomaterial is able to quickly reinforce the degraded spinal disc and help stabilize the motion of the associated spinal joint. Because of the capability to correct the core mechanical deficiencies in the spine, we believe this injectable device is able to reduce the resulting pain and disability while also resisting the wear and tear of the spinal disc tissues caused by overloading. There is nothing else like it for treating this often debilitating condition,” states Dr. Tom Hedman, Ph.D., the inventor and Adjunct Associate Professor within the F. Joseph Halcomb III, M.D. Department of Biomedical Engineering on the University of Kentucky.

About Intralink-Spine, Inc. (ILS)

ILS was fashioned to fabricate and promote the Réjuve™ medical gadget, supposed in Australia for the remedy of Degenerative Disc Disease (DDD), low again ache, and associated spinal ailments. ILS is conducting an energetic fundraising spherical for accredited traders; contact [email protected] for extra particulars.

Lyle Hawkins, Intralink-Spine Inc. 502.419.8099 or [email protected]

Most Popular

CIBC Innovation Banking Provides Eventus Systems with US$5 Million Growth Financing Facility

AUSTIN, Texas–(BUSINESS WIRE)–September 23, 2020– CIBC Innovation Banking today announced a US$5 million growth capital financing facility for Austin-based Eventus Systems Inc., a multi-award winning...

The Game Awards arrives December 10 with new accessibility honor

The Game Awards show is returning December 10 as an all-digital event with awards presentations, musical performances, and game premieres — this time in...

WhyLabs raises $4 million to grow AI and data monitoring platform

WhyLabs is launching out of stealth today with $4 million to grow its platform for data scientists who need help monitoring and troubleshooting problems...

Mastercard’s VP of AI talks bots, NLP, and why fintechs need AI for customer service (VB Live)

Presented by DefinedCrowd Companies like Mastercard are implementing AI strategies that are transforming how customer experience is done. Join this VB Live event for insights...

Recent Comments